Susceptibility Testing PowerPoint Presentations

2016
For details of User Group Days in 2016 please click here

2014
Isolation of carbapenemase-producing Enterobacteriaceae (CPE) from stool samples
Impact of MALDI-TOF on AST
The PHE CPE Toolkit and the need to detect Carbapenemase-Producing Enterobacteriaceae
Why some tests are no longer recommended

2012
Expert rules: Gram positives
Expert rules: Gram negatives
Internal Quality Assurance
NEQAS – how it works and what it tells us
Why do we need expert rules?

2011
Detecting carbapenemases in non fermenters
Detecting carbapenemases in Enterobacteriaceae
Questions & Answers

2010
Methods of detecting reduced susceptibility to glycopeptides in S.aureus
Automated systems: an overview
Our experiences with Phoenix
Vancomycin Susceptibility Testing in S.aureus
Vitek 2 – a user experience
EUCAST – Harmonising antimicrobial susceptibility testing in Europe
Questions & Answers

2009
ESBL Detection
Questions & Answers

2007
Shift to European (EUCAST) breakpoints – the impact on the BSAC recommendations
UGD_London_07_JP
BSAC recommendations for interpreting the susceptibility of urinary tract isolates
Susceptibility testing new agents eg. linezolid, tigecycline, daptomycin and dalbavancin
Detection of ESBLs and AmpC beta-lactamase

2006
BSAC Disc Diffusion Method
Confirmation tests for the detection of AmpC
Susceptibility testing anaerobes
General questions and answers about BSAC methodology
Clinical data to support the inerpretation of susceptibility testing of anaerobes

2005
Expert rules and inexpensive identificattion methods
Cefoxitlin for the detection of methicillin/oxacillian resistance in staphylococci
Antibacterial drug development
Most often asked questions
Expert rules and inexpensive identification methods

2004
Recent Changes to the Recommendations
Veterinary Susceptibility Testing
Detection of beta-lactamase-mediated resistance
Antimicrobial susceptibility testing in Europe – the role of national breakpoint committees and EUCAST
Does suceptibility testing have a role in predicting clinical or microbiological outcome?

2003
Determination of the antimicrobial susceptibility of Neisseria gonorrhoeae
Surveillance of Resistance
BSAC rolling programme for devising acceptable limits for control strains
Detection of beta-lactamase-mediated resistance
Quality Assurance of Antimicrobial Susceptibility Testing

Share thisShare on FacebookTweet about this on TwitterEmail this to someonePrint this page